Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 12, 2001

View Archived Issues

Start-Up Celogos Developing Therapies Using Adult Stem Cells

Pharmagene Signs BMS As First Subscriber To TargetEvaluator

Galapagos Renews Gene Function Alliance With Incyte Genomics

CeNeS Plans To Float Cognitive Testing Division On London AIM

PPL Gets Positive Data In Second Phase II BSSL Trial

European Commission Launches New Biotechnology Campaign

Senior PerkinElmer Executive To Lead Biotechnology Firm

Other News To Note

French Institute To Challenge Myriads BRCA1 Gene Patent

Genetic Detective Work Delivers A Mouse Model For Melanoma

Karo Bio, AHP Enter $100M Alliance In Atherosclerosis

Bio IT Raises $7.8M To Fund Computational Drug Discovery

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...